Sabine Bleul

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Journal: HemaSphere

Published: January 20, 2026

Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.

Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.

Journal: Cancer cell

Published: July 04, 2025

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Journal: Leukemia

Published: January 24, 2025

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

Journal: Leukemia

Published: January 24, 2025

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Journal: NPJ precision oncology

Published: April 29, 2024

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.

Journal: Neuro-oncology

Published: September 15, 2023

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.

Journal: BMC cancer

Published: June 29, 2023

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 21, 2022

Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy.

Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy.

Journal: Leukemia research

Published: August 05, 2020

Blastic transformation of BCR-ABL1 positive chronic myeloid leukaemia through acquisition of CBFB-MYH11 and mutant KIT.

Blastic transformation of BCR-ABL1 positive chronic myeloid leukaemia through acquisition of CBFB-MYH11 and mutant KIT.

Journal: British journal of haematology

Published: June 25, 2020

Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.

Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.

Journal: British journal of haematology

Published: May 27, 2020

Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction.

Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction.

Journal: Communications biology

Published: June 07, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026